CinRx Pharma Announces Additional $73 Million Financing
CinRx Pharma Announces Additional $73 Million Financing
CinDome Pharma Announces $40 Million Series B Extension
CinDome Pharma Announces $40 Million Series B Extension
CinRx Portfolio Company CinDome Pharma Presents Encouraging Data on Deudomperidone (CIN-102) at 2023 Digestive Disease Week® Conference
CinDome Pharma, a CinRx portfolio company, presented a poster at the 2023 Digestive Disease Week (DDW) Conference.